(Q43850408)

27 November 2017

title

Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining (English)

1 reference

27 November 2017

4

1 reference

27 November 2017

J G Jespersen

1

1 reference

27 November 2017

A Nedergaard

series ordinal

2

1 reference

27 November 2017

L L Andersen

series ordinal

3

1 reference

27 November 2017

J L Andersen

series ordinal

5

1 reference

27 November 2017

publication date

1 April 2011

1 reference

Scandinavian Journal of Medicine and Science in Sports

27 November 2017

published in

1 reference

27 November 2017

volume

21

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

215-223

1 reference

Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Neuromuscular adaptations to detraining following resistance training in previously untrained subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Functional improvement of dystrophic muscle by myostatin blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Role of myostatin in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Increased secretion and expression of myostatin in skeletal muscle from extremely obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Long term adrenal insufficiency induces skeletal muscle atrophy and increases the serum levels of active form myostatin in rat serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

The possible role of myostatin in skeletal muscle atrophy and cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Production of a monoclonal anti-myostatin antibody and the effects of in ovo administration of the antibody on posthatch broiler growth and muscle mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Regulation of muscle mass by myostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Myostatin and the control of skeletal muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Regulation of myostatin activity and muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Regulation of muscle growth by multiple ligands signaling through activin type II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Skeletal muscle adaptations to testosterone and resistance training in men with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Proteolytic processing of myostatin is auto-regulated during myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Myostatin is a procachectic growth factor during postnatal myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Redundancy of myostatin and growth/differentiation factor 11 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Signaling in muscle atrophy and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Smad2 and 3 transcription factors control muscle mass in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Myostatin mutation associated with gross muscle hypertrophy in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Modifying muscle mass - the endocrine perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Muscle growth after postdevelopmental myostatin gene knockout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

Induction of cachexia in mice by systemically administered myostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01044.X

10.1111/J.1600-0838.2009.01044.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference